🔗 Permalink

Inventor profile of:

Eric Marsault

City:

Sherbrooke

Country:

Canada

Published Applications:

19

Last publication date:

2020-03-12

Top Assignees for applications by Eric Marsault

The entities that hold a legal rights for patent applications filed by inventor Marsault Eric:

Ocera Therapeutics, Inc. 6 Palo Alto, CA United States
TRANZYME PHARMA INC. 3 Sherbrooke, Canada
SOCPRA Sciences et Génie s.e.c. 2 Sherbrooke, QC Canada
Tranzyme Pharma, Inc. 2 , Canada
TRANZYME PHARMA INC. 2 Quebec, Canada
SOCPRA Sciences Sante et Humaines S.E.C. 1 Sherbrooke, Quebec, Canada
Central Adelaide Local Health Network Inc. 1 Adelaide, Australia
SOCPRA SCIENCES ET GÉNIE S.E.C 1 Sherbrooke, Canada
McGill University 1 Montreal, Canada
SOCPRA SCIENCES ET GENIE S.E.C. 1 Sherbrooke, Canada
SOCPRA SCIENCES SANTE ET HUMAINES S.E.C. 1 SHERBROOKE, QC Canada
University Of South Australia 1 Adelaide, Australia
SOCPRA SCIENCES SANTE ET HUMAINES S.E.C. 1 Quebec, Canada

Recent patent applications by Marsault Eric

Eric Marsault from Sherbrooke, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-03-12

US20200079858A1

Chemistry; metallurgy

ANTIBODY CONJUGATE FOR TREATING AND DETECTING BLADDER CANCER

#2 | 2018-08-16

US20180228768A1

Human necessities

Macrocyclic ghrelin receptor modulators and methods of using the same

#3 | 2017-11-09

US20170320908A1

Chemistry; metallurgy

SOLID PHASE SYNTHESIS OF CYCLIC AMINO ACID MOLECULES

#4 | 2017-11-02

US20170314023A1

Chemistry; metallurgy

Matriptase inhibitors and uses thereof against orthomyxoviridae infections

#5 | 2017-02-16

US20170042858A1

Human necessities

Macrocyclic ghrelin receptor modulators and methods of using the same

#6 | 2016-08-04

US20160221927A1

Chemistry; metallurgy

Intermediates for macrocyclic compounds

#7 | 2016-04-07

US20160097052A1

Chemistry; metallurgy

Matriptase inhibitors and uses thereof against orthomyxoviridae infections

#8 | 2015-06-04

US20150150890A1

Human necessities

Guanine riboswitch binding compounds and their use as antibiotics

#9 | 2015-05-28

US20150148290A1

Chemistry; metallurgy

Macrocyclic modulators of the ghrelin receptor

#10 | 2014-03-27

US20140086936A1

Chemistry; metallurgy

Matriptase inhibitors and uses thereof against orthomyxoviridae infections

#11 | 2014-01-16

US20140018312A1

Human necessities

Steroid alkaloids and uses thereof as antimicrobial agents against electron transport-deficient microbes and as potentiators for antimicrobial agents against pathogenic bacteria

#12 | 2012-05-17

US20120122819A1

Human necessities

GUANINE RIBOSWITCH BINDING COMPOUNDS AND THEIR USE AS ANTIBIOTICS

#13 | 2009-09-24

US20090240027A1

Chemistry; metallurgy

Intermediates for macrocyclic compounds

#14 | 2009-09-03

US20090221689A1

Chemistry; metallurgy

Pharmaceutical salts of macrocyclic modulators of the ghrelin receptor

#15 | 2008-08-14

US20080194672A1

Human necessities

Macrocyclic ghrelin receptor modulators and methods of using the same

#16 | 2005-06-23

US20050137127A1

Chemistry; metallurgy

Conformationally-controlled biologically active macrocyclic small molecules as motilin antagonists or ghrelin agonists

#17 | 2005-06-02

US20050119169A1

Chemistry; metallurgy

Spatially-defined macrocycles incorporating peptide bond surrogates

#18 | 2005-03-10

US20050054562A1

Chemistry; metallurgy

Macrocyclic antagonists of the motilin receptor

#19 | 2005-03-01

US10253981

Preparation of phosphorothioate oligomers

InventorID:

615187 ⎘